You have 9 free searches left this month | for more free features.

Cell therapy

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aggressive NK Cell Leukemia Trial in Hiroshima (PPMX-T003)

Recruiting
  • Aggressive NK Cell Leukemia
  • Hiroshima, Japan
    Hiroshima University Hospital
May 9, 2023

Real World Data on Ibrutinib Use in PCNSL Rel/Ref

Recruiting
  • PCNSL
  • Milan, Italy
    Ospedale San Raffaele
Mar 13, 2023

Glioma, Glioneuronal Tumor, Choroid Plexus Tumor Trial (Observational)

Not yet recruiting
  • Glioma
  • +12 more
  • Observational
  • (no location specified)
Feb 17, 2022

Tumor Infiltrating Lymphocytes, Safety, Advanced Solid Tumor Trial in Beijing (TIL therapy)

Recruiting
  • Tumor Infiltrating Lymphocytes
  • +5 more
  • TIL therapy
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 19, 2022

Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)

Not yet recruiting
  • Chronic Kidney Diseases
  • Placebo
  • Vitamin K 2
  • (no location specified)
Jul 4, 2023

Myeloid Tumor Trial in Memphis (CPX-351, MHA)

Recruiting
  • Myeloid Neoplasm
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 20, 2023

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 6, 2023

Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)

Completed
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer

Active, not recruiting
  • Metastatic Lung Non-Small Cell Squamous Carcinoma
  • +7 more
  • Los Angeles, California
  • +9 more
Dec 17, 2022

Chronic Lymphocytic Leukemia- Binet Staging System Trial in Spain (Acalabrutinib 100 MG Oral Capsule)

Recruiting
  • Chronic Lymphocytic Leukemia- Binet Staging System
  • Acalabrutinib 100 MG Oral Capsule
  • A Coruña, Spain
  • +20 more
Jan 17, 2022

Tuberculous Meningitis Trial in China (Isoniazid)

Unknown status
  • Tuberculous Meningitis
  • Beijing, China
  • +3 more
Jan 28, 2021

Cytomegalovirus Infection After HSCT and PT-CY as GVHD

Completed
  • CMV Infection
    • Malaga, Spain
      Maria Jesus Pascual
    Mar 30, 2022

    Covid19 Trial in Germany (CRP-apheresis)

    Recruiting
    • Covid19
    • CRP-apheresis
    • Essen, NRW, Germany
    • +3 more
    Mar 29, 2022

    Rare Diseases, Genetic Predisposition to Disease Trial in Tübingen (WGS Diagnostic Blood take for genetic diagnostic., Hair

    Recruiting
    • Rare Diseases
    • Genetic Predisposition to Disease
    • WGS Diagnostic Blood take for genetic diagnostic.
    • Hair collection
    • Tübingen, Germany
    • +1 more
    May 17, 2022

    NSCLC Trial in Amsterdam, Groningen, Maastricht (Afatinib, Cetuximab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Amsterdam, North-Holland, Netherlands
    • +3 more
    Oct 19, 2021

    Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)

    Terminated
    • Triple-Negative Breast Neoplasms
    • +3 more
    • Tucson, Arizona
    • +53 more
    Feb 24, 2022

    Peanut Hypersensitivity, Food Allergy, Food Hypersensitivity Trial in Chapel Hill, Dallas (Liquid Peanut Extract, Placebo

    Completed
    • Peanut Hypersensitivity
    • +3 more
    • Liquid Peanut Extract
    • Placebo Glycerin SLIT
    • Chapel Hill, North Carolina
    • +1 more
    Dec 19, 2021

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • Rochester, New York
      University of Rochester
    Feb 7, 2022

    Solid Tumor, Adult, NSCLC, Urothelial Carcinoma Trial (BA3071, Nivolumab)

    Not yet recruiting
    • Solid Tumor, Adult
    • +8 more
    • BA3071
    • Nivolumab
    • (no location specified)
    Jan 5, 2022

    Follicular Lymphoma Trial in Worldwide (tisagenlecleucel)

    Active, not recruiting
    • Follicular Lymphoma
    • tisagenlecleucel
    • Duarte, California
    • +29 more
    Nov 2, 2022

    Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)

    Completed
    • Advanced Gastric Adenocarcinoma
    • Seoul, Korea, Republic of
      Samsung Medical center
    Jun 13, 2022

    DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

    Recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • Follicular Lymphoma
    • Lenalidomide combined with G-CHOP (LO CHOP)
    • Xiamen, Fujian, China
      Bing Xu
    Nov 28, 2023

    Cancer Trial in Wuhan (RD133)

    Recruiting
    • Cancer
    • Wuhan, Hubei, China
      Tongji Hospital of Tongji Medical College, Huazhong University o
    Apr 26, 2022

    HER2 Positive Advanced Gastric Cancer Trial in Beijing (Samples including blood and tissue collection, CTC detection, ctDNA

    Recruiting
    • HER2 Positive Advanced Gastric Cancer
    • Samples including blood and tissue collection
    • +5 more
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Apr 20, 2022

    Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Carrilizumab, bevacizumab,capecitabine
    • (no location specified)
    Jul 20, 2023